vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in vTv Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −4 vs. Q1 2023
- Shares held
- 3.52M
- −53.2K (−1.5%) vs. Q1 2023
- Total value
- $2.60M
- −$281.8K (−9.8%) vs. Q1 2023
- New holders
- 1
- 5 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 109 | $0 | 0.00% | −372−77.3% | Reduced |
| BNP Paribas Arbitrage, SA | 329 | $243 | 0.00% | 00.0% | Unchanged |
| Sunbelt Securities, Inc. | 600 | $444 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 750 | $555 | 0.00% | +750 | New |
| Wells Fargo & Company | 1,229 | $909 | 0.00% | +9+0.7% | Added |
| Parallel Advisors, LLC | 1,500 | $1.11K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,060 | $1.52K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 5,183 | $3.83K | 0.00% | +5,107+6,719.7% | Added |
| Strengthening Families & Communities, LLC | 6,884 | $5.00K | 0.00% | −258−3.6% | Reduced |
| Focused Wealth Management, Inc | 10,000 | $7.40K | 0.00% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 30,000 | $22.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 33,442 | $24.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 50,416 | $37.3K | 0.00% | +9,839+24.2% | Added |
| BlackRock Inc. | 55,134 | $40.8K | 0.00% | +44+0.1% | Added |
| Susquehanna International Group, LLP | 76,251 | $56.4K | 0.00% | +60,981+399.4% | Added |
| State Street Corp | 134,745 | $99.7K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 242,937 | $179.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 289,347 | $214.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 939,623 | $695.1K | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,635,509 | $1.21M | 0.21% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −43,787−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −33,270−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −27,018−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,238−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −959−100.0% | Sold out |